Prevention of metabolic syndrome from atypical antipsychotic medications: (Record no. 22363)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01950nam a22002297a 4500 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 130411t2012 nju||||| |||| 00| 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 0279-3695 |
| 082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Edition number | 21 |
| Classification number | 050/P24 |
| 085 ## - SYNTHESIZED CLASSIFICATION NUMBER COMPONENTS | |
| Number where instructions are found-single number or beginning number of span | AI 050/P24 |
| 085 ## - SYNTHESIZED CLASSIFICATION NUMBER COMPONENTS | |
| -- | 21 |
| Number where instructions are found-single number or beginning number of span | AI 050/P24 |
| 040 ## - CATALOGING SOURCE | |
| Transcribing agency | |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Parrinello, Michael C. |
| 245 ## - TITLE STATEMENT | |
| Title | Prevention of metabolic syndrome from atypical antipsychotic medications: |
| Remainder of title | applying Rogers' diffusion of innovations model in clinical practice./ |
| 246 ## - VARYING FORM OF TITLE | |
| Title proper/short title | Journal of Psychosocial Nursing and Mental Health Services. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1 fig.; 1 table; refs. |
| 362 ## - DATES OF PUBLICATION AND/OR SEQUENTIAL DESIGNATION | |
| Dates of publication and/or sequential designation | v.50, no. 12 (December 2012): 36-44. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Patients who are taking atypical antipsychotic medications have a high incidence of metabolic complications, including increased weight, waist circumference, blood sugar, lipid levels, and blood pressure. In 2004, the American Diabetic Association and three other associations, including the American Psychiatric Association, developed guidelines to screen for metabolic syndrome, but in practice, adherence to the guidelines vary. This article describes a process to implement the guidelines in a suburban psychiatric day treatment hospital using Rogers' Diffusion of Innovations model. Measurement of waist circumference was identified as an opportunity to improve the current metabolic screening protocol. Post-intervention evaluation revealed increased adherence to the guidelines (0% pre versus 95% post). Adherence to the guidelines demonstrates the effect of the systematic application of Rogers' model on acceptance of practice change. Fully implementing the guidelines meets recommendations for the standard of practice and can improve the health and quality of life of patients prescribed atypical antipsychotic medications. |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | PSYCHOTROPIC DRUGS. |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | ROGERS' DIFFUSION OF INNOVATION MODEL. |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | |
| Koha item type | Periodicals Journal Bound |
No items available.
